In Vitro Antifungal Activity of Three Synthetic Peptides against <i>Candida auris</i> and Other <i>Candida</i> Species of Medical Importance

Candidiasis is an opportunistic infection affecting immunosuppressed and hospitalized patients, with mortality rates approaching 40% in Colombia. The growing pharmacological resistance of <i>Candida</i> species and the emergence of multidrug-resistant <i>Candida auris</i> are...

Full description

Saved in:
Bibliographic Details
Main Authors: Richar Torres (Author), Adriana Barreto-Santamaría (Author), Gabriela Arévalo-Pinzón (Author), Carolina Firacative (Author), Beatriz L. Gómez (Author), Patricia Escandón (Author), Manuel Alfonso Patarroyo (Author), Julián E. Muñoz (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c2212f073e0e4bde83a677d4c0d2a4d0
042 |a dc 
100 1 0 |a Richar Torres  |e author 
700 1 0 |a Adriana Barreto-Santamaría  |e author 
700 1 0 |a Gabriela Arévalo-Pinzón  |e author 
700 1 0 |a Carolina Firacative  |e author 
700 1 0 |a Beatriz L. Gómez  |e author 
700 1 0 |a Patricia Escandón  |e author 
700 1 0 |a Manuel Alfonso Patarroyo  |e author 
700 1 0 |a Julián E. Muñoz  |e author 
245 0 0 |a In Vitro Antifungal Activity of Three Synthetic Peptides against <i>Candida auris</i> and Other <i>Candida</i> Species of Medical Importance 
260 |b MDPI AG,   |c 2023-07-01T00:00:00Z. 
500 |a 10.3390/antibiotics12081234 
500 |a 2079-6382 
520 |a Candidiasis is an opportunistic infection affecting immunosuppressed and hospitalized patients, with mortality rates approaching 40% in Colombia. The growing pharmacological resistance of <i>Candida</i> species and the emergence of multidrug-resistant <i>Candida auris</i> are major public health problems. Therefore, different antimicrobial peptides (AMPs) are being investigated as therapeutic alternatives to control candidiasis effectively and safely. This work aimed to evaluate the in vitro antifungal activity of three synthetic AMPs, PNR20, PNR20-1, and 35409, against ATCC reference strains of <i>Candida albicans</i>, <i>Candida glabrata</i>, <i>Candida parapsilosis</i>, <i>Candida krusei</i>, and <i>Candida tropicalis</i>, and clinical isolates of <i>C. auris</i>. Antifungal susceptibility testing, determined by broth microdilution, showed that the AMPs have antifungal activity against planktonic cells of all <i>Candida</i> species evaluated. In <i>C. auris</i> and <i>C. albicans</i>, the peptides had an effect on biofilm formation and cell viability, as determined by the XTT assay and flow cytometry, respectively. Also, morphological alterations in the membrane and at the intracellular level of these species were induced by the peptides, as observed by transmission electron microscopy. In vitro, the AMPs had no cytotoxicity against L929 murine fibroblasts. Our results showed that the evaluated AMPs are potential therapeutic alternatives against the most important <i>Candida</i> species in Colombia and the world. 
546 |a EN 
690 |a <i>Candida auris</i> 
690 |a <i>Candida</i> spp. 
690 |a antimicrobial peptides 
690 |a antifungal resistance 
690 |a candidiasis 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antibiotics, Vol 12, Iss 8, p 1234 (2023) 
787 0 |n https://www.mdpi.com/2079-6382/12/8/1234 
787 0 |n https://doaj.org/toc/2079-6382 
856 4 1 |u https://doaj.org/article/c2212f073e0e4bde83a677d4c0d2a4d0  |z Connect to this object online.